Filing Impact
Filing Sentiment
Form Type
25-NSE
Verve Therapeutics, Inc.
Aug 14, 2025
[SCHEDULE 13G] Verve Therapeutics, Inc. SEC Filing
Aug 14, 2025
[SCHEDULE 13G/A] Verve Therapeutics, Inc. SEC Filing
Aug 4, 2025
[15-12G] Verve Therapeutics, Inc. SEC Filing
Jul 28, 2025
[SCHEDULE 13G/A] Verve Therapeutics, Inc. SEC Filing
994.04M
84.54M
5.1%
94.69%
4.06%
Biotechnology
Pharmaceutical Preparations
United States
BOSTON